AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide- 1-β-d-ribofuranoside (aicar) reduces lipoteichoic acid-induced lung inflammation

32Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: AMPK is a highly conserved energy homeostasis-regulating kinase. Results: Activation of AMPK by AICAR in vitro reduced cytokine production in alveolar macrophage cell line and in vivo reduced LTA-induced neutrophil influx, protein leak and cytokine/chemokine levels. Conclusion: AMPK activation inhibits LTA-induced lung inflammation in mice. Significance: AICAR reduces LTA inflammation. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Hoogendijk, A. J., Pinhanços, S. S., Van Der Poll, T., & Wieland, C. W. (2013). AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide- 1-β-d-ribofuranoside (aicar) reduces lipoteichoic acid-induced lung inflammation. Journal of Biological Chemistry, 288(10), 7047–7052. https://doi.org/10.1074/jbc.M112.413138

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free